The Role of Src Kinase inMacrophage-Mediated Inflammatory Responses

被引:200
作者
Byeon, Se Eun [1 ]
Yi, Young-Su [1 ]
Oh, Jueun [1 ]
Yoo, Byong Chul [2 ]
Hong, Sungyoul [1 ]
Cho, Jae Youl [1 ]
机构
[1] Sungkyunkwan Univ, Dept Genet Engn, Suwon 446746, South Korea
[2] Res Inst & Hosp, Natl Canc Ctr, Goyang 410769, South Korea
基金
新加坡国家研究基金会;
关键词
PROTEIN-TYROSINE KINASES; NF-KAPPA-B; FC-GAMMA-RII; TNF-ALPHA PRODUCTION; C-SRC; FAMILY KINASES; KUPFFER CELLS; SIGNAL-TRANSDUCTION; LIPOTEICHOIC ACID; ETHANOL EXTRACT;
D O I
10.1155/2012/512926
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Src kinase (Src) is a tyrosine protein kinase that regulates cellular metabolism, survival, and proliferation. Many studies have shown that Src plays multiple roles in macrophage-mediated innate immunity, such as phagocytosis, the production of inflammatory cytokines/mediators, and the induction of cellular migration, which strongly implies that Src plays a pivotal role in the functional activation of macrophages. Macrophages are involved in a variety of immune responses and in inflammatory diseases including rheumatoid arthritis, atherosclerosis, diabetes, obesity, cancer, and osteoporosis. Previous studies have suggested roles for Src in macrophage-mediated inflammatory responses; however, recently, new functions for Src have been reported, implying that Src functions in macrophage-mediated inflammatory responses that have not been described. In this paper, we discuss recent studies regarding a number of these newly defined functions of Src in macrophage-mediated inflammatory responses. Moreover, we discuss the feasibility of Src as a target for the development of new pharmaceutical drugs to treat macrophage-mediated inflammatory diseases. We provide insights into recent reports regarding new functions for Src that are related to macrophage-related inflammatory responses and the development of novel Src inhibitors with strong immunosuppressive and anti-inflammatory properties, which could be applied to various macrophage-mediated inflammatory diseases.
引用
收藏
页数:18
相关论文
共 163 条
[21]   A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity [J].
Chong, YP ;
Mulhern, TD ;
Zhu, HJ ;
Fujita, DJ ;
Bjorge, JD ;
Tantiongco, JP ;
Sotirellis, N ;
Lio, DSS ;
Scholz, G ;
Cheng, HC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (20) :20752-20766
[22]   Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases [J].
Chong, YP ;
Ia, KK ;
Mulhern, TD ;
Cheng, HC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2) :210-220
[23]   Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells [J].
Chowdhury, AK ;
Watkins, T ;
Parinandi, NL ;
Saatian, B ;
Kleinberg, ME ;
Usatyuk, PV ;
Natarajan, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (21) :20700-20711
[24]   Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration [J].
Chun, Jarin ;
Prince, Alice .
JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 86 (05) :1135-1144
[25]   The immunopathogenesis of sepsis [J].
Cohen, J .
NATURE, 2002, 420 (6917) :885-891
[26]   Src-related protein tyrosine kinases in hematopoiesis [J].
Corey, SJ ;
Anderson, SM .
BLOOD, 1999, 93 (01) :1-14
[27]   ACTIVATION OF SRC FAMILY KINASES BY COLONY STIMULATING FACTOR-I, AND THEIR ASSOCIATION WITH ITS RECEPTOR [J].
COURTNEIDGE, SA ;
DHAND, R ;
PILAT, D ;
TWAMLEY, GM ;
WATERFIELD, MD ;
ROUSSEL, MF .
EMBO JOURNAL, 1993, 12 (03) :943-950
[28]   The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10 [J].
Dahle, MK ;
Overland, G ;
Myhre, AE ;
Stuestol, JF ;
Hartung, T ;
Krohn, CD ;
Mathiesen, O ;
Wang, JE ;
Aasen, AO .
INFECTION AND IMMUNITY, 2004, 72 (10) :5704-5711
[29]   Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck [J].
Dal Porto, JM ;
Burke, K ;
Cambier, JC .
IMMUNITY, 2004, 21 (03) :443-453
[30]  
DeFranco AL, 1998, PROG CLIN BIOL RES, V397, P119